TIME ponders whether Vytorin is a failure:
In the meantime, doctors are likely to dial back on their use of Vytorin. “If they aren’t getting to the target goal [cholesterol level] with generic simvastatin, then because this study is raising questions I think a lot of physicians will think about switching to higher doses of drugs like Lipitor or Crestor before going to Vytorin.”
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
